Quris provides an artificial intelligence platform that predicts which drug candidates will safely work in humans.
Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharma companies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 20, 2022 | Seed | $9M | 5 | SoftBank Vision Fund | — | Detail |
Jan 11, 2022 | Seed | $19M | 3 | Welltech Ventures | — | Detail |
Oct 18, 2021 | Seed | $9M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SoftBank Vision Fund | Yes | Seed |
GlenRock Israel | — | Seed |
iAngels | — | Seed |
Richter Group | — | Seed |
Welltech Ventures | — | Seed |
Judith Richter | — | Seed |
Kobi Richter | — | Seed |
Moshe Yanai | — | Seed |